Insider Trading Alert - CMN, ASFI And HNRG Traded By Insiders

Yesterday, Dec. 31, 2015, 26 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $23.73 to $1,310,562.24.

Highlighted Stocks Traded by Insiders:

Cantel Medical (CMN) - FREE Research Report

Krakauer Andrew A, who is Ceo at Cantel Medical, sold 9,438 shares at $62.49 on Dec. 31, 2015. Following this transaction, the Ceo owned 143,341 shares meaning that the stake was reduced by 6.18% with the 9,438-share transaction.

The shares most recently traded at $62.14, down $0.35, or 0.56% since the insider transaction. Historical insider transactions for Cantel Medical go as follows:

  • 4-Week # shares sold: 9,438
  • 12-Week # shares sold: 32,419
  • 24-Week # shares sold: 72,296

The average volume for Cantel Medical has been 137,200 shares per day over the past 30 days. Cantel Medical has a market cap of $2.7 billion and is part of the health care sector and health services industry. Shares are up 46.42% year-to-date as of the close of trading on Wednesday.

Cantel Medical Corp. provides infection prevention and control products and services in the healthcare market. The company operates through Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis segments. The stock currently has a dividend yield of 0.19%. The company has a P/E ratio of 52.3. Currently, there is 1 analyst who rates Cantel Medical a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CMN - FREE

TheStreet Quant Ratings rates Cantel Medical as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Cantel Medical Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Trade-Ideas: Cantel Medical (CMN) Is Today's Strong And Under The Radar Stock

Cantel Medical's New CEO Jorgen B. Hansen to 'Close a Couple of Deals' in 'Near Future'

Today's Strong And Under The Radar Stock: Cantel Medical (CMN)

Cantel Medical (CMN) Highlighted As Strong And Under The Radar Stock Of The Day